Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Add-on Reparixin in Adult Patients With ARDS

ClinicalTrials.gov ID: NCT05496868

Public ClinicalTrials.gov record NCT05496868. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 10:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Assess Efficacy and Safety of Reparixin as add-on Therapy to SoC in Acute Respiratory Distress Syndrome (RESPIRATIO)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study objectives 1. To characterize the efficacy of reparixin in ameliorating lung injury and systemic inflammation and expediting clinical recovery and liberation from mechanical ventilation in adult patients with moderate to severe ARDS (PaO2/FIO2 ratio ≤ 200). 2. to assess the effect of reparixin on systemic biomarkers linked to a hyper-inflammatory ARDS phenotype. 3. To evaluate the safety of reparixin vs. placebo in patients enrolled in the study.

Study identification

NCT ID
NCT05496868
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dompé Farmaceutici S.p.A
Industry
Enrollment
66 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 6, 2022 (Actual)
Primary completion
Mar 18, 2025 (Actual)
Completion
Apr 18, 2025 (Actual)
Last update posted
May 11, 2026

2022 – 2025

United States locations

U.S. sites
33
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
The University of Alabama at Birmingham Hospital Birmingham Alabama 35233 —
Banner - University Medical Center Phoenix Phoenix Arizona 85006 —
University of Southern California Los Angeles California 90033 —
University of California Irvine Health Orange California 92868 —
Unversity of California Davis Medical Center Sacramento California 95817 —
Denver Health Denver Colorado 80204 —
University of South Florida Tampa Florida 33606 —
Emory Saint Joseph's Hospital Atlanta Georgia 30342 —
Methodist Hospitals of Northwest Indiana Gary Indiana 46404 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Newton Wellesley Hospital Newton Massachusetts 02462-1607 —
Baystate Health Springfield Massachusetts 01107 —
Detroit Medical Center Detroit Michigan 48201 —
Henry Ford Hospital Detroit Michigan 48202 —
MyMichigan Medical Center Midland Midland Michigan 48670 —
William Beaumont Hospital Royal Oak Michigan 48073 —
Jackson Pulmonary Associates Jackson Mississippi 39202 —
University of Missouri Health Care Columbia Missouri 65212 —
Hackensack Meridian Health Hackensack New Jersey 07601 —
NYU Langone Brooklyn Brooklyn New York 11220 —
New York University Langone Health New York New York 10016 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
University of Oklahoma Medical Center Oklahoma City Oklahoma 73104 —
Oregon Health and Science University Portland Oregon 97239 —
University of Tennessee Medical Center Knoxville Tennessee 37920 —
Baptist Hospitals of Southeast Texas Beaumont Texas 77701 —
University of Texas Southwestern Medical Center Dallas Texas 75390-8894 —
Cardiovoyage Denison Texas 75020 —
Houston Methodist Hospital Houston Texas 77030 —
University of Utah Hospitals & Clinics Salt Lake City Utah 84108 —
Virginia Commonwealth University Health System Richmond Virginia 23298 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05496868, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05496868 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →